GLP-1 Compounding Pharmacies Lose Bid To Stay Removal Of Drug From Shortage List
FORT WORTH, Texas — A Texas federal judge refused to grant a preliminary injunction and stay on the U.S. Food and Drug Administration’s decision to remove an FDA-approved drug for diabetes...To view the full article, register now.
Already a subscriber? Click here to view full article